A patient-centric approach to optimise insulin therapy in Asia

Goh, Su-Yen; Ang, Ernesto; Bajpai, Shailendra; Deerochanawong, Chaicharn; Hong, Eun Gyoung; Hussein, Zanariah; Joshi, Shashank; Kamaruddin, Nor Azmi; Kho, Sjoberg A.; Kong, Alice Pik Shan; Pan, Chang Yu; Perfetti, Riccardo; Vichayanrat, A; Vlajnic, Aleksandra; Chan, Juliana C.N.

doi:10.1016/j.jdiacomp.2016.05.019

Cited by 2 publications

(2 citation statements)

References 55 publications

(72 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These are vital PX dimensions that indicate the impact of organizational strategies on consumer gratifications, engagement and patronizing intentions (Anderson and Smith, 2018;Senapati and Panda, 2024). These aspects ensure that both patient and provider stay aware of the collaborative opportunities and work as partners rather than sole decision-makers (Goh et al, 2016). Despite the proliferation of cross-cultural PX studies, a fragmented focus either on singular care or specific disease has limited the generalizability and adaptability of experiential elements in healthcare contexts (Wolf et al, 2021).…”

Section: Review Of Literaturementioning

confidence: 99%

Section: Review Of Literaturementioning

confidence: 99%

See 1 more Smart Citation

Performance measurement of factors affecting consumer experience in healthcare services using fuzzy and grey techniques

Senapati,

Panda

2024

IJHG

View full text Add to dashboard Cite

PurposeThe importance of consumer experience in service industries, particularly healthcare, is widely acknowledged as it captures the intricacies of quality management. In tandem with the emerging research trends that evaluate service excellence through user experience, this study renders a performance analysis of the dimensions of consumer experience that individually or collectively shape healthcare consumers’ perceptions of service quality.Design/methodology/approachA cross-sectional study was conducted across 13 mid-tier corporate hospitals to collect data from 438 patients. The data was processed through factor analysis in SPSS to confirm sample adequacy and factor extractability. Further, two independent multi-criteria decision-making (MCDM) tools, Fuzzy Technique for Order Performance by Similarity to Ideal Solution (F-TOPSIS) and Grey Relational Analysis (GRA), were executed to render performance analysis of identified factors.FindingsUsing F-TOPSIS, factors such as “information” and “hospital environment” received higher performance ratings, while items related to “communication with doctors” and “humanistic care” received lower rankings. Minor yet anticipated deviations were observed while verifying performance scores using GRA. Nonetheless, both outcomes exhibited a strong correlation coefficient of 97.14%, confirming analytical consistency.Originality/valueHitherto, such usages of hybrid MCDM techniques have rarely been executed to convey a clear understanding of consumers’ experiences in healthcare services. Moreover, the findings provide a clear insight into consumers’ key response areas, which can further be translated to maximize consumer gratification, thus assisting healthcare managers in improving service performance and clinical decision-making.

show abstract

Section: Review Of Literaturementioning

confidence: 99%

Section: Review Of Literaturementioning

confidence: 99%

Performance measurement of factors affecting consumer experience in healthcare services using fuzzy and grey techniques

Senapati,

Panda

2024

IJHG

View full text Add to dashboard Cite

show abstract

Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study

Hong,

Min,

Lim

et al. 2024

Adv Ther

Self Cite

View full text Add to dashboard Cite

Introduction The TOujeo BEyond glucose control (TOBE) study evaluated clinical outcomes with insulin glargine 300 units/mL (Gla-300) in insulin-naïve Korean people with type 2 diabetes mellitus (T2DM) in a real-world setting. Methods This 24-week, prospective, non-interventional, multicenter, open-label, single-arm, observational study included adults aged ≥ 20 years with T2DM suboptimally controlled with oral hypoglycemic agents and/or glucagon-like peptide 1 receptor agonists who require basal insulin. Eligible participants were assigned to either general target glycated hemoglobin (HbA1c < 7%) or individualized target groups as per physician’s discretion considering guidelines and participants’ characteristics. The primary endpoint was the proportion of participants achieving the HbA1c target (individualized or general) at 24 weeks. Results Among 369 participants, 19.5% (72/369) of participants achieved the HbA1c target at week 24; 37.5% (33/88) in the individualized and 13.9% (39/281) in the general target group. In both target groups, similar reductions in fasting plasma glucose and body weight were observed, with low incidence of hypoglycemia, and T2DM duration was significantly shorter in participants who did versus those who did not achieve the target HbA1c (individualized target group: 9.6 ± 8.0 versus 13.1 ± 8.4 years, P = 0.0454; general target group: 10.2 ± 8.6 versus 12.8 ± 7.4 years, P = 0.0378). Conclusions This study showed that initiation of insulin therapy with Gla-300 in people with T2DM using an individualized approach is more effective in achieving an HbA1c target. Moreover, earlier initiation of insulin therapy in people with suboptimally controlled T2DM may increase the success rate of glycemic control. A graphical abstract is available with this article. Graphical Abstract Supplementary Information The online version contains supplementary material available at 10.1007/s12325-024-02830-z.

show abstract

A patient-centric approach to optimise insulin therapy in Asia

Cited by 2 publications

References 55 publications

Performance measurement of factors affecting consumer experience in healthcare services using fuzzy and grey techniques

Performance measurement of factors affecting consumer experience in healthcare services using fuzzy and grey techniques

Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study

Contact Info

Product

Resources

About